Christopher Kimberlin BS, PhD

Chris Kimberlin did his graduate work at The Scripps Research Institute using structural biology to understand key mechanisms in pathogenesis of filoviruses under the mentorship of Dr. Erica Ollmann Saphire. He then moved to Dr. Daniel Minor’s group at UC San Francisco for his postdoctoral work studying structure and mechanisms of ion channel regulation. Chris is currently at Pfizer, CID in South San Francisco working on the development of antibody based therapeutics for the treatment of cancer.